A murine model of enterohemorrhagic Escherichia coli O157:H7 infection to assess immunopotentiating activity of drugs on mucosal immunity: Effect of drugs

Journal Pharmacological Sciences

Volumn 91, Issue 3, 2003, Pages 219-228

  Nagano, Keiji ^a   Sugisaki, Takeshi ^a   Taguchi, Kazuki ^a   Hara, Takumi ^a   Naiki, Mitsuru ^b   Mori, Hiroshi ^a  

^a GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

^b Nippon Zoki Pharmaceutical Co   (Japan)

Author keywords

Enterohemorrhagic Escherichia coli O157; Immunopotentiator; Mucosal immunization; Murine model; Neurotropin

Indexed keywords

CHOLERA TOXIN; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; NEUROTROPIN; OVALBUMIN; TACROLIMUS;

ACTIVE IMMUNIZATION; ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIGEN SPECIFICITY; ARTICLE; BACTERIAL STRAIN; CHRONIC DISEASE; CONTROLLED STUDY; DEFENSE MECHANISM; DRUG EFFECT; DRUG POTENTIATION; ENTEROBACTER INFECTION; ESCHERICHIA COLI O157; FEMALE; GASTROINTESTINAL HEMORRHAGE; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOPHARMACOLOGY; IMMUNOSTIMULATION; INOCULATION; INTESTINE INFECTION; MOUSE; MOUTH INFECTION; MUCOSAL IMMUNITY; NONHUMAN; PATHOGENESIS;

EID: 0037687895     PISSN: 13478613     EISSN: None     Source Type: Journal    
DOI: 10.1254/jphs.91.219     Document Type: Article

References (42)

1. Ogra PL: Mucosal immunity and infections. In Mucosal Immunology, Edited by Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J and McGhee JR, pp 657-738, Academic Press, New York (1999)
2. Russel MW, Kilian M and Lamm ME: Biological activities of IgA. In Mucosal Immunology, Edited by Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J and McGhee JR, pp 225-240, Academic Press, New York (1999)
3. McGhee JR: Mucosal vaccines. In Mucosal Immunology, Edited by Ogra PL, Mestecky J, Lamm ME, Strober W, Bienenstock J and McGhee JR, pp 741-933, Academic Press, New York (1999)
4. Matroeni P, Bowe F, Cahill R, Simmons C and Dougan G: Vaccines against gut pathogens. Gut 45, 633-635 (1999)
5. Ogra PL, Faden H and Welliver RC: Vaccination strategies for mucosal immune responses. Clin Microbiol Rev 14, 430-445 (2001)
6. Jertborn M, Nordstrom I, Kilander A, Czerkinsky C and Holmgren J: Local and systemic immune responses to rectal administration of recombinant cholera toxin B subunit in humans. Infect Immun 69, 4125-4128 (2001)
7. Johansson EL, Wassen L, Holmgren J, Jertborn M and Rudin A: Nasal and vaginal vaccinations have differential effects on antibody responses in vaginal and cervical secretions in humans. Infect Immun 69, 7481-7486 (2001)
8. Cohen D, Orr N, Haim M, Ashkenazi S, Robin G, Green MS, Ephros M, Sela T, Slepon R, Ashkenazi I, Taylor DN, Svennerholm AM, Eldad A and Shemer J: Safety and immunogenicity of two different lots of the oral, killed enterotoxigenic Escherichia coli-cholera toxin B subunit vaccine in Israeli young adults. Infect Immun 68, 4492-4497 (2000)
9. Jertborn M, Ahren C and Svennerholm AM: Dose-dependent circulating immunoglobulin A antibody-secreting cell and serum antibody responses in Swedish volunteers to an oral inactivated enterotoxigenic Escherichia coli vaccine. Clin Diagn Lab Immunol 8, 424-428 (2001)
10. O'Brien AD and Kaper JB: Shiga toxin-producing Escherichia coli: Yesterday, today, and tomorrow. In Escherichia Coli O157:H7 and Other Shiga Toxin-Producing E Coli Strains, Edited by Kaper JB and O'Brien AD, pp 1-11, American Society for Microbiology, Washington, DC (1998)
11. Nataro JP and Kaper JB: Diarrheagenic Escherichia coli. Clin Microbiol Rev 11, 142-201 (1998)
12. Paton JC and Paton AW: Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infecitons. Clin Microbiol Rev 11, 450-479 (1998)
13. Nagano K, Taguchi K, Hara T, Yokoyama S, Kawada K and Mori H: Adhesion and colonization of enterohemorrhagic Escherichia coli O157:H7 in cecum of mice. Microbiol Immunol 47, 125-132 (2003)
14. Itoh S, Kariya M, Nagano K, Yokoyama S, Fukao T, Yamazaki Y and Mori H: New rapid enzyme-linked immunosorbent assay to detect antibodies against bacterial surface antigens using filtration plates. Biol Pharm Bull 25, 986-990 (2002)
15. Inagaki M, Ohno K, Ohta S, Sakuraba H and Takeshita K: Relief of chronic burning pain in Fabry disease with neurotropin. Pediatr Neurol 6, 211-213 (1990)
16. Kaku H, Fujita Y, Yago H, Naka F, Kawakubo H, Nakano K, Nishikawa K and Suehiro S: Study on pruritus in hemodialysis patients and the antipruritic effect of neurotropin: Plasma levels of substance P, somatostatin, IgE, PTH and histamine. Nippon Jinzo Gakkai Shi 32, 319-326 (1990)
17. Yago H, Fujita Y, Kaku H, Naka F, Nishikawa K, Kawakubo H, Nakano K, Matsumoto K and Suehiro S: Study on pruritus in hemodialysis patients and the antipruritic effect of neurotropin: Plasma levels of C3a, C5a, bradykinin and lipid peroxides. Nippon Jinzo Gakkai Shi 31, 1061-1067 (1989)
18. Takeichi N, Ba D, Koga Y and Kobayashi H: Immunologic suppression of carcinogenesis in spontaneously hypertensive rats (SHR) with T cell depression. J Immunol 130, 501-505 (1983)
19. Yanagihara Y, Shida T and Yoshii H: Immunopharmacological actions of neutropin. (1). Immunostimulating actions of neurotropin. Folia Pharmacol Jpn (Nippon Yakurigaku Zasshi) 78, 439-449 (text in Japanese with English abstract)
20. Mori H, Kurimoto Y, Xu QA and Koda A: Effect of a non-protein fraction from an extract of the inflamed skin of rabbits inoculated with vaccinia virus (Neurotropin) on Meth A-induced delayed type hypersensitivity. Jpn J Pharmacol 54, 468-472 (1990)
21. Teshima H, Sogawa H, Kihara H, Kubo C, Mori K and Nakagawa T: Prevention of immunosuppression in stressed mice by Neurotropin (NSP). Life Sci 47, 869-876 (1990)
22. Matsuoka T, Yoshii H and Suehiro S: Immunological action of neurotropin (5). Effect of neurotropin on immunosuppression caused by stress. Folia Pharmacol Jpn (Nippon Yakurigaku Zasshi) 90, 67-71 (1987) (text in Japanese with English abstract)
23. Yoshii H, Tatsumi S, Matsuoka T, Suehiro S, Konishi J, Yanagihara Y, Negoro S and Kishimoto S: Immunopharmacological actions of an extract isolated from inflamed skin of rabbits inoculated with vaccinia virus (Neurotropin™)-II. Restorative effect on immune responses through the recovery of IL-2 production in aging mice. Int J Immunopharmac 11, 543-550 (1989)
24. Tomoda T, Nakano Y and Kageyama T: The effect of Neurotropin supply against intestinal bacteria umbalance during the administration of immunosuppressive drugs. Igaku To Seibutsugaku 104, 261-264 (1982) (in Japanese)
25. Ba D, Suzuki K, Takeichi N and Kobayashi H: Restoration of immune functions in T-cell depressed spontaneously hypertensive rats (SHR) by injection of Neurotropin. Hokkaido J Med Sci 56, 355-357 (1981) (text in Japanese with English abstract)
26. 2 receptors in spinal dorsal horn. Life Sci 62, 2181-2190 (1998)
27. Westphal O and Jann K: Bacterial lipopolysaccharides extraction with phenol-water and further applications of the procedure. In Methods in Carbohydrate Chemistry, Edited by Whistler RL, Vol 5, pp 83-93, Academic Press, New York and London (1965)
28. Westerman RB, He Y, Keen JE, Littledike ET and Kwang J: Production and characterization of monoclonal antibodies specific for the lipopolysaccharide of Escherichia coli O157. J Clin Microbiol 35, 679-684 (1997)
29. Droge W, Lehmann V, Luderitz O and Westphal O: Structural investigations on the 2-keto-3-deoxyoctonate region of lipopolysaccharides. Eur J Biochem 14, 175-184 (1970)
30. Mori H, Natarajan K, Betschart B, Weiss N and Franklin RM: Polyclonal B-cell activation and autoantibody formation during the course of mosquito-transmitted Plasmodium berghei infection in mice. Trop Med Parasit 38, 157-162 (1987)
31. Yoshii H, Matsuoka T, Kurimoto Y and Suehiro S: Immuno-modulating effect of Neurotropin on delayed type hypersensitivity response in mice. Jpn J Pharmacol 47, 433-435 (1988)
32. Sherman P, Soni R, Petric M and Karmali M: Surface properties of the Vero cytotoxin-producing Escherichia coli O157:H7. Infect Immun 55, 1824-1829 (1987)
33. McKee ML and O'Brien AD: Investigation of enterohemorrhagic Escherichia coli O157:H7 adherence characteristics and invasion potential reveals a new attachment pattern shared by intestinal E. coli. Infect Immun 63, 2070-2074 (1995)
34. Donnenberg MS, Donohue-Rolfe A and Keusch GT: Epithelial cell invasion: An overlooked property of enteropathogenic Escherichia coli (EPEC) associated with the EPEC adherence factor. J Infect Dis 160, 452-459 (1989)
35. Dibb-Fuller MP, Best A, Stagg DA, Cooley WA and Woodward MJ: An in-vitro model for studying the interaction of Escherichia coli O157:H7 and other enteropathogens with bovine primary cell cultures. J Med Microbiol 50, 759-769 (2001)
36. Oelschlaeger TA, Barrett TJ and Kopecko DJ: Some structures and processes of human epithelial cells involved in uptake of enterohemorrhagic Escherichia coli O157:H7 strains. Infect Immun 62, 5142-5150 (1994)
37. Uhlich GA, Keen JE and Elder RO: Variations in the csgD promoter of Escherichia coli O157:H7 associated with increased virulence in mice and increased invasion of HEp-2 cells. Infect Immun 70, 395-399 (2002)
38. Schreiber SL and Crabtree GR: The mechanism of action of cyclosporin A and FK506. Immunol Today 13, 136-142 (1992)
39. Bierer BE, Hollander G, Fruman D and Burakoff SJ: Cyclosporin A and FK506: Molecular mechanisms of immunosuppression and probes for transplantation biology. Cur Opin Immunol 5, 763-773 (1993)
40. Yamamoto M, Rennert P, McGhee JR, Kweon MN, Yamamoto S, Dohi T, Otake S, Bluethmann H, Fujihashi K and Kiyono H: Alternate mucosal immune system: Organized Peyer's patches are not required for IgA responses in the gastrointestinal tract. J Immunol 164, 5184-5191 (2000)
41. Xu-Amano J, Kiyono H, Jackson RJ, Staats HF, Fujihashi K, Burrows PD, Elson CO, Pillai S and McGhee JR: Helper T cell subsets for immunoglobulin A responses: Oral immunization with tetanus toxoid and cholera toxin as adjuvant selectively induces Th2 cells in mucosa associated tissues. J Exp Med 178, 1309-1320 (1993)
42. Ruedl C, Rieser C, Kofler N, Wick G and Wolf H: Humoral and cellular immune responses in the murine respiratory tract following oral immunization with cholera toxin or Escherichia coli heat-labile enterotoxin. Vaccine 14, 792-798 (1996)